Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype

Journal of Pathology

Volumn 179, Issue 3, 1996, Pages 254-259

  Marchetti, Antonio ^a   Buttitta, Fiamma ^a   Pellegrini, Silvia ^a   Chella, Antonio ^a   Bertacca, Gloria ^b   Filardo, Alberto ^a   Tognoni, Vittorio ^a   Ferreli, Francesca ^a   Signorini, Elena ^a   Angeletti, Carlo Alberto ^a   Bevilacqua, Generoso ^a  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

bronchioloalveolar; differentiation; histology; K ras; lung cancer

Indexed keywords

ARTICLE; CODON; GENE EXPRESSION; GENE MUTATION; HISTOGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CARCINOMA; PRIORITY JOURNAL; SCLEROSIS; TUMOR GROWTH;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADENOCARCINOMA, MUCINOUS; BASE SEQUENCE; FEMALE; GENES, RAS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION;

EID: 9444260917     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199607)179:3<254::AID-PATH589>3.0.CO;2-J     Document Type: Article

References (44)

1. Liebow AA. Bronchiolo-alveolar carcinoma. Adv Intern Med 1960; 10: 329-358.
2. Clayton F. The spectrum and significance of bronchioloalveolar carcinomas. Pathol Annu 1988; 23: 361-394.
3. Donaldson JC, Kaminsky DB, Elliot CR. Bronchiolar carcinoma. Report of 11 cases and review of the literature. Cancer 1978; 41: 250-258.
4. Edgerton R, Rao U, Takita H, Vincent RG. Bronchioloalveolar carcinoma. A clinical overview and bibliography. Oncology 1981; 38: 269-273.
5. Epstein DM. Bronchioloalveolar carcinoma. Sem Roentgenol 1990; 25: 105-111.
6. Auerbach O., Garfinkel L. The changing pattern of lung carcinoma. Cancer 1991; 68: 1973-1977.
7. Barsky SH, Cameron R, Osann KE, Tomita D, Holmes EC. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer 1994; 73: 1163-1170.
8. Edwards CW. Alveolar carcinoma: a review. Thorax 1984; 39: 166-174.
9. Marcq M, Galy P. Bronchioloalveolar carcinoma: clinicopathologic relationships, natural history, and prognosis in 29 cases. Am Rev Respir Dis 1973; 107: 621-629.
10. Liebow A. Bronchiolar-alveolar carcinoma. Adv Intern Med 1960; 10: 329-358.
11. Barsky SH, Huang S, Bhuta S. The extracellular matrix of pulmonary scar carcinomas is suggestive of a desmoplastic origin. Am J Pathol 1986; 124: 412-419.
12. Bonne C. Morphological resemblance of pulmonary adenomatosis (jaagsiekte) in sheep and certain cases of cancer of the lung in man. Am J Cancer 1939; 35: 491-501.
13. Falk RT, Pickle LW, Fontham ETH, et al. Epidemiology of bronchioloalveolar carcinoma. Can Epidem Biomark Prev 1992; 1: 339-344.
14. Morabia A, Wynder EL. Relation of bronchioloalveolar carcinoma to tobacco. Br Med J 1992; 304: 541-543.
15. Ives JL, Buffler PA, Greenberg SD. Environmental associations and histologic patterns of carcinoma of the lung: the challenge and dilemma in epidemiologic studies. Am Rev Respir Dis 1983; 128: 195-209.
16. Manning JT, Spjut HJ, Tschen JA. Bronchioloalveolar carcinoma: the significance of two histopathologic types. Cancer 1984; 54: 525-534.
17. Bleehen NM, Rabbitts PH, Reeve JG. Report on the 3rd JASLC Lung Tumor Biology Workshop. 1990, August 6-9; Robinson College, Cambridge. Lung Cancer 1991; 7: 171-178.
18. Ohory NP, Yousem SA, Griffin J, Stanis K, Stetler-Stevenson WG, Colby TV. Comparison of extracellular matrix antigens in subtypes of bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study. Am J Surg Pathol 1992; 16: 675-686.
19. Barsky SH, Grossman D, Ho J, Holmes EC. The multifocality of bronchioloalveolar lung carcinoma (BAC): evidence and implications of a multiclonal origin. Mod Pathol 1992; 5: 112A.
20. Shraufnagel D. Peloquin A, Pare JAP, Wang NS. Differentiating bronchioloalveolar carcinoma from adenocarcinoma. Am Rev Respir Dis 1982; 125: 74-79.
21. Greco RJ, Steiner RM, Goldman S, Cotler H, Patchefsky A, Cohn HE. Bronchoalveolar cell carcinoma of the lung. Ann Thorac Surg 1986; 41: 652-656.
22. Watson WL, Farpour A. Terminal bronchiolar or 'alveolar cell' cancer of the lung. Two hundred and sixty-five cases. Cancer 1960; 19: 776-780.
23. Bennet DE, Sasset WF. Bronchiolar carcinoma: a valid clinicopathologic entity? A study of 30 cases. Cancer 1969; 24: 876-887.
24. Shimosato Y, Kodama T, Kameya T. Morphogenesis of peripheral type adenocarcinoma of the lung. In: Shimosato Y, Melamed MR, Nettesheim P, eds. Morphogenesis of Lung Cancer. Vol. 1. Boca Raton, FL: CRC Press, 1982; 65-90.
25. Shimosato Y, Suzuki A, Hashimoto T. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancer. Am J Surg Pathol 1980; 4: 365.
26. Suzuki A. Growth characteristics of peripheral type adenocarcinoma of the lung in tumours of roentgenologic findings. In: Shimosato Y, Melamed MR, Nettesheim P, eds. Morphogenesis of Lung Cancer. Vol. 1. Boca Raton, FL: CRC Press, 1982; 9-109.
27. Madri JA, Carter D. Scar cancer of the lung: origin and significance. Hum Pathol 1984; 15: 625.
28. Barski SH, Huang SJ, Bhuta S. The extracellular matrix of pulmonary scar carcinomas is suggestive of desmoplastic origin. Am J Pathol 1986; 124: 412.
29. World Health Organization. Histological typing of lung tumours. Am J Clin Pathol 1982; 77: 123-136.
30. Rodenhuis S, Slebos RJC. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 1992; 52: 2665s-2669s.
31. Kobayashi T, Tsuda H, Noguchi M, et al. Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes. Cancer 1990; 66: 289-294.
32. Rusch VW, Reuter VE, Kris MG, et al. Ras oncogene point mutation: an infrequent event in bronchioloalveolar cancer. J Thor Cardiov Surg 1992; 104: 1465-1469.
33. Rosenblat MB, Lisa JR, Collier F. Primary and metastatic bronchioloalveolar carcinoma. Dis Chest 1967; 52: 147-156.
34. Smit VTHBM, Boot AJM, Smits AMM, Fleuren GJ, Cornelisse CJ, Bos JL. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 1988; 16: 7773-7782.
35. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89 (Suppl. 4): 225S-233S.
36. Slebos RJC, Boerrigter L, Evers SG, Wisman P, Mooi WJ, Rodenhuis S. A rapid and simple procedure for the routine detection of ras mutations in formalin-fixed, paraffin-embedded tissues. Diagn Mol Pathol 1992; 1: 136-141.
37. Verlaan de Vries M, Bogaard ME, van den Elst H, van Boom JH, van der Eb AJ, Bos JL. A dot-blot screening procedure for mutated ras genes using synthetic oligodeoxynucleotides. Gene 1986; 50: 313-320.
38. Satoh T, Nakafuku M, Kaziro Y. Function of ras as a molecular switch in signal transduction. J Biol Chem 1992; 267: 24149-24152.
39. Yanagisawa A, Ohtake K, Ohashi K, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993; 53: 953-956.
40. DiGiuseppe JA, Hruban RH, Offerhaus GJ, et al. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 1994; 144: 889-895.
41. Ichikawa Y, Nishida M, Suzuki H, et al. Mutations of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Res 1994; 54: 33-35.
42. Westra WH, Slebos RJC, Offerhaus GJA, et al. K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. Cancer 1993; 72: 432-438.
43. Li Z-H, Zheng J, Weiss LM, Shibata D. c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol 1994; 144: 303-309.
44. Dixon AY, Moran JF, Wesselius LJ, McGregor DH. Pulmonary mucinous cystic tumor. Case report with review of the literature. Am J Surg Pathol 1993; 17: 722-728.